Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 September 2018

What can or should higher education contribute to transformation and development by advancing the human well-being and agency of all students? How would our universities need to change to truly foster human development? 

These are the common questions cutting across the papers which will be presented at the International colloquium on ‘Researching well-being, agency and structural inequalities: comparative perspectives’. The University of the Free State’s (UFS) South African Research Chairs Initiative (SARChI) Chair in higher education and human development research programme led by Prof Melanie Walker will host the colloquium on 19 September 2018 at the Bloemfontein Campus.

The colloquium presents critical scholarship on development and also serves to celebrate the second five-year term of the SARChI Chair. The event has been structured to enable opportunities for early career researchers from the UFS to present their work alongside that of experienced scholars from the UK, US and South Africa, working on human development, development ethics and on education.
 
Date: Wednesday 19 September 2018
Time: 09:00-17:00
Venue: Chancellor’s Room, Centenary Complex, Bloemfontein Campus

Enquiries: Contact Elize Rall at rall.elize@gmail.com or on 076 792 9999 and CC Lucretia Smith at SmithL3@ufs.ac.za or dial 051 401 9856.

Click on the attached documents for the invitation and programme

News Archive

HIV Cure – Just another fantasy?
2016-07-27

Description: HIV Cure – Just another fantasy? Tags: HIV Cure – Just another fantasy?

Dr Dominique Goedhals, Prof John Frater,
Dr Thabiso Mofokeng and Dr Jacob Jansen van Vuuren,
attended the lecture. Prof Frater has been working in
collaboration with the UFS Department of Internal
Medicine on HIV resistance and HIV immunology
since 2007.

Photo: Nonsindiso Qwabe

Twenty-years ago, after a person had been diagnosed with HIV, their lifespan did not exceed three years, but thanks to the success of antiretroviral therapy programmes, life expectancy has risen by an average of ten years. However, is antiretroviral therapy always going to be for life? This is the societal issue that Professor John Frater, addressed in his talk at the University of the Free State. He is an MRC Senior Clinical Fellow, Associate Professor and Honorary Consultant Physician in Infectious Diseases at  Oxford University.

Antiretroviral medicine therapeutic

The discovery of antiretroviral therapy - the use of HIV medicines to treat the virus - has had a positive effect on the health and well-being of people living with it, improving their quality of life. Unfortunately, if treatment is stopped, HIV rebounds to the detriment of the patient. Now, research has shown that some patients, who are treated soon after being infected by HIV, may go off treatment for prolonged periods. Work is being done to predict who will be able to stop treatment.

“The difference made by starting treatment earlier is enormous. Delaying treatment is denying yourself the right to health,” Professor Frater says. However, this does not mean that the virus is cured. “A person can live for ten years without being on HIV treatment, but is that enough?” he went on to ask.

Healthy lifestyles encouraged

The National Department of Health will adopt a test and treat immediately strategy later this year to improve patient health and curb the spread of HIV. ,This is another reason why everybody should know their status and start treatment as soon as possible.

Search for a cure continues

More research is being conducted to establish whether HIV can be eradicated. Remission gives hope that a permanent cure may be found eventually. “Will a cure for HIV ever be found? Time will tell,” he concluded.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept